CY1109314T1 - Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης - Google Patents

Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης

Info

Publication number
CY1109314T1
CY1109314T1 CY20091100878T CY091100878T CY1109314T1 CY 1109314 T1 CY1109314 T1 CY 1109314T1 CY 20091100878 T CY20091100878 T CY 20091100878T CY 091100878 T CY091100878 T CY 091100878T CY 1109314 T1 CY1109314 T1 CY 1109314T1
Authority
CY
Cyprus
Prior art keywords
donepezil
pharmaceutical composition
amporative
hydrochlor
composition contained
Prior art date
Application number
CY20091100878T
Other languages
English (en)
Inventor
Miha Vrbinc
Kolar Alesa Puncuh
Franc Vrecer
Jordan Berta Kotar
Veronika Stangelj
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Publication of CY1109314T1 publication Critical patent/CY1109314T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σταθεροποιημένες φαρμακευτικές συνθέσεις με μία άμορφη μορφή της υδροχλωρικής 1 - βενζυλ-4-((5,6-διμεθοξυ-1-ινδανον)-2-υλ)μεθυλ-πιπεριδίνης (ντονεπεζίλη) και μέθοδο για τη σταθεροποίηση αυτής της ένωσης. Η φαρμακευτική σύνθεση παρασκευάζεται με in situ σχηματισμό υδροχλωρικής ντονεπεζίλης και φόρτωμα του λαμβανόμενου διαλύματος επί ενός μίγματος φαρμακευτικώς αποδεκτών εκδόχων. Η άμορφη μορφή της υδροχλωρικής ντονεπεζίλης σταθεροποιείται με προσθήκη ενός αναστολέα κρυστάλλωσης στο διάλυμα ή στο μίγμα των φαρμακευτικώς αποδεκτών εκδόχων.
CY20091100878T 2002-06-19 2009-08-17 Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης CY1109314T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200155A SI21223A (sl) 2002-06-19 2002-06-19 Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
EP03741747A EP1513528B1 (en) 2002-06-19 2003-06-18 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride

Publications (1)

Publication Number Publication Date
CY1109314T1 true CY1109314T1 (el) 2014-07-02

Family

ID=29778199

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100878T CY1109314T1 (el) 2002-06-19 2009-08-17 Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης

Country Status (15)

Country Link
EP (1) EP1513528B1 (el)
AT (1) ATE431739T1 (el)
AU (1) AU2003279102A1 (el)
CY (1) CY1109314T1 (el)
DE (1) DE60327696D1 (el)
DK (1) DK1513528T3 (el)
EA (1) EA012904B1 (el)
ES (1) ES2326529T3 (el)
HR (1) HRP20041198B1 (el)
PL (1) PL212584B1 (el)
PT (1) PT1513528E (el)
RS (1) RS51824B (el)
SI (2) SI21223A (el)
UA (1) UA86573C2 (el)
WO (1) WO2004000317A1 (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150509A (en) 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
IL154370A0 (en) * 2003-02-10 2003-09-17 Chemagis Ltd Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
CA2552221A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
KR20070083679A (ko) 2004-09-29 2007-08-24 케마지스 리미티드 약학적으로 순수한 비정질 도네페닐 염산염의 제조를 위한정제된 도네페질 말레산염의 용도
ATE415148T1 (de) * 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
WO2006063025A1 (en) * 2004-12-07 2006-06-15 Nektar Therapeutics Stable non-crystalline formulation comprising donepezil
US20060122226A1 (en) 2004-12-08 2006-06-08 Itai Adin Crystalline forms of Donepezil base
RU2401125C2 (ru) 2004-12-27 2010-10-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ стабилизации лекарственного средства против деменции
JP2007015934A (ja) * 2005-07-05 2007-01-25 Meiko Shoji Kk 温感クリーム化粧料
DE102005060377A1 (de) 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
DE102009041839A1 (de) * 2009-09-18 2011-03-24 Dolorgiet Gmbh & Co. Kg Donepezil-haltige Tabletten
EP2366378A1 (en) * 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Sustained-release donepezil formulations
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (en) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil
WO2013135852A1 (en) 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR122019024673B1 (pt) 2013-12-04 2023-04-11 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
EP3380079A4 (en) * 2015-11-25 2019-08-21 Patheon Development Services Inc. AMORPHOUS DISPERSION GRANULES AND PHARMACEUTICAL FORMS FOR ORAL USE
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
KR102372630B1 (ko) * 2019-05-15 2022-03-14 주식회사 대웅제약 고함량의 도네페질 또는 그의 염을 포함하는 경피흡수제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
AU731282B2 (en) * 1996-06-07 2001-03-29 Eisai Co. Ltd. Polymorphs of donepezil hydrochloride and process for production
ES2310164T3 (es) * 1999-02-10 2009-01-01 Pfizer Products Inc. Dispositivo de liberacion controlada por la matriz.
CA2359945C (en) * 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion

Also Published As

Publication number Publication date
HRP20041198A2 (en) 2005-04-30
DK1513528T3 (da) 2009-09-07
AU2003279102A1 (en) 2004-01-06
PL372116A1 (en) 2005-07-11
RS110604A (en) 2007-02-05
EP1513528B1 (en) 2009-05-20
EA012904B1 (ru) 2010-02-26
PT1513528E (pt) 2009-08-18
EP1513528A1 (en) 2005-03-16
ES2326529T3 (es) 2009-10-14
HRP20041198B1 (hr) 2013-05-31
ATE431739T1 (de) 2009-06-15
EA200500040A1 (ru) 2005-06-30
SI1513528T1 (sl) 2009-10-31
PL212584B1 (pl) 2012-10-31
WO2004000317A1 (en) 2003-12-31
UA86573C2 (ru) 2009-05-12
DE60327696D1 (de) 2009-07-02
RS51824B (en) 2012-02-29
SI21223A (sl) 2003-12-31

Similar Documents

Publication Publication Date Title
CY1109314T1 (el) Φαρμακευτικη συνθεση περιεχουσα σταθεροποιημενη αμορφη μορφη της υδροχλωρικης ντονεπεζιλης
CY1121812T1 (el) Φαρμακοτεχνικη μορφη ταχειας διαλυτοποιησης η οποια περιλαμβανει σινακαλσετη hcl
NO20051871L (no) Opioidreseptorantagonister
JP2003506406A5 (el)
PE20050349A1 (es) Compuestos de aril o heteroaril amida
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
UA84146C2 (ru) Амиды пирролопиридин-2-карбоновой кислоты как ингибиторы гликогенфосфорилазы, способ их получения, фармацевтическая композиция и их применение как терапевтических агентов для лечения заболеваний
NO20040301L (no) Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
HUP0101511A2 (hu) 1-[(1-Szubsztituált-4-piperidinil)-metil]-4-piperidin-származékok, eljárás a vegyületek előállítására, a vegyületeket tartalmazó gyógyászati készítmények és intermedierjeik
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
NO990671D0 (no) Muskarinantagonistiske etere
EA200970148A1 (ru) Фармацевтический состав, содержащий донепезил
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
ATE519486T1 (de) Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
MX9703025A (es) Proceso para preparar levobupivacaina y sus analogos.
KR19990028807A (ko) 디페닐메틸렌 피페리딘 유도체
ATE403426T1 (de) Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
PL1761492T3 (pl) Szczawian 1-benzylo-4-[(5,6-dimetoksy-1-indanon)-2-ylo]metylopiperydyny (szczawian donepezilu) i jego polimorfy
NO20052491L (no) Nye vitronektinresepotr antagonistderivater, fremgangsmate til deres fremstilling, anvendelse derav som legemidler og farmasoytiske sammensetninger som inneholder de samme
WO2005007642A3 (en) Novel azaheterocyclic amides useful for treating pain
NZ543068A (en) Substituted 4-(alkyl-amide)-piperidine derivatives, processes for their preparation, and pharmaceutical compositions containing them
DE60220953D1 (de) Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon
CY1106900T1 (el) Χρηση παραγωγων πυριδιν-2-υλμεθυλαμινης για τη θεραπεια συμπτωματων χρονιου πονου νευροπαθους ή ψυχογενους προελευσης
HUP0204297A2 (hu) (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények